All Brands Owned by Merck & Co.
Merck & Co. owns 11 brands in our database. Browse the complete portfolio of Merck & Co. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Rahway, New Jersey, USA
Brand Portfolio
11 brands
Stock
NYSE: MRK
Filter by Category
Complete Brand Portfolio
Bridion
Owned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Gardasil
Owned by Merck & Co.
Prescription human papillomavirus vaccine for preventing cervical cancer and other HPV-related cancers, manufactured and marketed by Merck & Co.
Isentress
Owned by Merck & Co.
Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.
Januvia
Owned by Merck & Co.
Prescription diabetes medication for treating type 2 diabetes by increasing insulin secretion, manufactured and marketed by Merck & Co.
Keytruda
Owned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Nuvaxovid
Owned by Merck & Co.
Novavax's protein-based COVID-19 vaccine using recombinant nanoparticle technology and Matrix-M adjuvant, FDA emergency use authorized July 13, 2022, with a biologics license application (BLA) approved May 19, 2025, offering a protein subunit alternative to mRNA-based COVID-19 vaccines for adults and adolescents.
Pepcid
Owned by Merck & Co.
Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.
Propecia
Owned by Merck & Co.
Prescription medication for treating male pattern baldness by inhibiting hair loss, manufactured and marketed by Merck & Co.
RotaTeq
Owned by Merck & Co.
Merck's live oral pentavalent rotavirus vaccine (RV5), FDA approved February 3, 2006, developed by Paul Offit and colleagues at Children's Hospital of Philadelphia, containing five human-bovine reassortant rotavirus strains (G1, G2, G3, G4, and P1A) administered as a 3-dose oral series to infants, recommended by the CDC for routine infant immunization.
Singulair
Owned by Merck & Co.
Prescription medication for treating asthma and allergies by reducing inflammation in the airways, manufactured and marketed by Merck & Co.
Vaseretic
Owned by Merck & Co.
Prescription combination medication for treating high blood pressure, manufactured and marketed by Merck & Co.
About Merck & Co.
What does Merck & Co. own?
Merck & Co. owns a portfolio of pharmaceutical products, vaccines, and animal health products. The company's major brands include Keytruda (oncology immunotherapy), Gardasil (HPV vaccine), Winrevair (pulmonary arterial hypertension), Januvia/Janumet (diabetes), Bridion (anesthesia reversal), and various other prescription medicines. Merck also operates an animal health division under the Merck Animal Health brand, providing veterinary medicines and vaccines.
Is Merck & Co. publicly traded?
Yes, Merck & Co., Inc. trades on the New York Stock Exchange under ticker symbol MRK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group, BlackRock, and State Street.
What is Merck's annual revenue?
In FY2024, Merck reported worldwide sales of $64.2 billion, a 7% increase from FY2023. The Pharmaceutical segment generated approximately $57.4 billion and the Animal Health segment approximately $5.8 billion. Keytruda alone accounted for approximately $29.5 billion in FY2024 sales.
Who is Merck's CEO?
Robert M. Davis has served as Chairman and Chief Executive Officer of Merck & Co. since 2021, succeeding Kenneth Frazier. Davis has led the company's strategy of building a post-Keytruda pipeline through acquisitions and internal research investment.
Stock Information
Competitors to Merck & Co.
No competing brands found in the same categories. This could be because Merck & Co.operates in unique market segments or we're still building our competitor database.
Merck & Co. Brand Portfolio Overview
Merck & Co. maintains a diverse portfolio of 11 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 11 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Merck & Co.provides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Merck & Co.
Latest News About Merck & Co.
Articles About Merck & Co.
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
Monthly M&A Roundup: June 2026 Brand Ownership Changes
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.